Novartis Belux

Last year, we continued our commitment at Novartis BeLux to prevent mortality from cardiovascular diseases – one of Belgium's leading causes of death. We are on a mission to improve heart health in collaboration with patient associations, healthcare professionals and healthcare organizations among other parties in the healthcare ecosystem and beyond. In 2024, we worked diligently to further improve access to the right treatment and care at the right time, and build a better understanding of atherosclerosis and cardiovascular risk factors, alongside the Ligue Cardiologique Belge / Belgische Cardiologische Liga. As our colleagues are our best ambassadors and their heart health is paramount, they could have their cholesterol checked and participate in CPR training at work. Additionally, twenty colleagues, alongside seven ‘heart ambassadors’, enthusiastically embarked on a personalized training program as part of our official healthcare partnership with Golazo Energy for the EU Running Championships. 🏃♀️ In 2025, we continue this mission to help save lives by addressing the preventable deaths due to cardiovascular diseases – because every heartbeat matters. ❤️ #NovartisTogether #ThrowbackThursday #CVD #NovartisPeople #LetItBeat

As 2024 comes to a close, we’re taking a moment to reflect on a year filled with purpose, progress and partnerships at Novartis Belux. We’re inspired by the impact we can make when we work together, alongside industry experts, patient organisations, policymakers and our incredible employees. 🙌 From bonding with colleagues through community service activities, to being recognized as a Leading Employer and bringing healthcare decision makers and our innovative medicines industry association pharma.be to our production facility in Puurs – it has been an incredible and memorable experience! Guided by our core values Inspired, Curious and Unbossed, and driven by our learning mindset, we’ve pushed boundaries to reimagine medicine and extend and improve people’s lives. A heartfelt ‘thank you’ to our passionate and dedicated employees for making 2024 truly inspiring! Here’s to 2025 as we continue to create meaningful change, together. 🌟 #NovartisTogether

We’re ready to “Let it Beat”. 💓 In collaboration with Golazo Energy and Ligue Cardiologique Belge / Belgische Cardiologische Liga, we kicked off a unique training program for 27 ambassadors to take on the challenge of training for a 10 km or half marathon with special care for heart health. In this video, you'll hear about the ambassadors’ first impressions and the program’s goals and running tips by Siegrid De Ridder and Simon Van Langenhove. Gina Volkaert explains how this initiative and managing your risk factors can contribute to saving lives given that 80% of cardiovascular diseases are preventable. Get ready to follow the ambassadors’ journey—and maybe even join the movement! Learn more about the program here: NL 👉 https://lnkd.in/ezHrbrr4 FR 👉 https://lnkd.in/eP5tRPYa #NovartisTogether #LetItBeat #HeartHealth #EuropeanRunningChampionships2025

In its Report to Society, pharma.be – of which our country president Federico Mambretti is a board member – looks back on 2024. It was a year with challenges when it comes to European competitiveness and fast and broad access to medicines, but also one of continued innovation in our Belgian pharma valley. Three highlights from the report: 🥇 Belgium is number one when it comes to investments in research & development per capita. Every day, the sector invests 15,5 million euro in R&D. 🔬 When it comes to clinical research, Belgium holds the top position – although this is under pressure. Clinical trials are crucial in the development of new medicines, while they also provide patients with access to the newest treatments before they are on the market. 🎯 Radioligand therapy, an important new pillar in the fight against cancer, gained a lot of traction in 2024. Research institutes, patient associations, public services, etc. worked together on the ‘RLT action plan’ to make the Belgian healthcare system RLT-proof and ensure that people with cancer can have access to this pioneering therapy. We are proud of how Novartis has contributed to a healthier society and we look forward to continuing our efforts in improving and extending people’s lives, with a firm belief in tomorrow's opportunities. Interested in reading pharma.be’s full report? Watch the video (https://lnkd.in/ewvDEHpv) or dive into the full report: 👉 NL: https://lnkd.in/eZUauhvs 👉 FR: https://lnkd.in/eU5DxwWw

In Belgium, around 110 to 220 people live with paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disorder which can be life-threatening. Those living with PNH are at risk of thrombosis, and low hemoglobin levels can lead to symptomatic anemia, fatigue and other symptoms that can affect their overall wellbeing. Due to its rarity and complex symptoms, PNH can be hard to diagnose, with individuals waiting an average of 2 years for a diagnosis. Timely intervention is essential for people with PNH. That’s why, at Novartis, we are committed to help raise awareness of PNH and find ways for patients to live a life free from the impact of PNH and its symptoms. #PNH #ReimagineMedicine FA-11324924, 4 December 2024

Quality is a key priority in all areas of our work. Patients and healthcare practitioners rightfully expect from us the highest quality standards. It is a collective responsibility within our organization, not confined solely to our Quality team. In recognition of World Quality Week earlier this month, the team organized an escape room experience to emphasize this shared commitment. Colleagues had to look for clues in order to get a live-changing medicine in time to a patient. Besides great fun, it was also a nice educational refresher to immerse colleagues in the critical work of ensuring high standards. Our Medical Science Liaisons and Study & Site Operations team rocked it with an escape in just 39 minutes and 29 seconds! 🏆 Congratulations Silke Vermaerke Jelka Van De Vliet Julien De Poortere Hannah De Baere Tine Schepers Nele Decruy Nina Wegge! #WorldQualityWeek #QualityFirst #NovartisTogether 

As the official healthcare partner of the European Running Championships, taking place in April 2025, we want to emphasize the importance of taking care of your heart. To walk (run 😉) the talk, we are – together with the Ligue Cardiologique Belge / Belgische Cardiologische Liga – looking for 8 ambassadors with a heart condition and/or a high cholesterol to get ready for the 10 km run or half-marathon. They will take part in an exclusive 4-month training program designed by Golazo Energy. Interested? Or do you know someone who would be a great match? 👇 FR: https://lnkd.in/e6p7jCJH NL: https://lnkd.in/eRv9r3Za 📅 Applications are open until Thursday, 28 November! #NovartisTogether #HeartHealth #LetItBeat #EuropeanRunningChampionships2025

80% of cardiovascular diseases are preventable. It all starts with being aware of our risk factors and taking care of our heart. 💓 Whether it's getting active (with daily walks or... by participating in a half-marathon!), having a balanced diet, managing stress, or keeping up with regular health check-ups: each step can play a key role in heart health. That’s why we have at heart to be the official healthcare partner of the first-ever European Running Championships organized by Golazo Group in April 2025, supporting your journey to a healthier heart. 🏃♂️ It will be an historic event where athletes of all levels - amateurs and professionals - will share the same starting line. Join the movement towards better heart health, one stride at a time. Let it beat! For more info: https://lnkd.in/eSZzS_d3 #NovartisTogether #HeartHealth #europeanrunningchampionships2025

Innovation only matters when it reaches those who need it. 🌍💊   Today we want to share a piece of news we are really proud of: Novartis has been ranked first in the 2024 Access to Medicine Index. This recognition reinforces our commitment to improving access to breakthrough medicines for people around the world, regardless of their location or socio-economic status.    While we are grateful for this recognition, there is still a large unmet need for medicines —some life-changing, others potentially life-saving— and we are committed to further broaden access to innovation and create sustainable impact.   Thank you to our 70,000+ associates around the globe and our partners who work tirelessly to make inclusive healthcare a reality. Because every patient matters. Everywhere.   #ReimagineMedicineTogether #AccessToMedicine #HealthEquity   Access to Medicine Foundation

In her 15-year journey with us, Tamara Haentjens has exemplified the spirit of growth and innovation at Novartis Belux. Starting in regulatory affairs, Tamara was responsible for the clinical trial submissions to, and follow-up on, Medical Need and Compassionate Use programs with the health authorities - given her previous work experience, this was a chance to build upon her knowledge on these topics. While in regulatory affairs, she had the opportunity to do a job rotation in what was then known as market access, eventually joining the Value & Access team. Tamara's career is an example to our commitment to professional development. Her story highlights the power of flexibility at Novartis, offering her the opportunity to navigate her career path while contributing significantly to patient care. Her ability to balance professional aspirations with personal commitments, especially in light of her family needs, underscores the supportive and flexible work culture we champion. Tamara's journey is one of inspiration and impact, showcasing the possibilities that arise from a nurturing environment where learning and innovation flourish. #NovartisTogether #NovartisLife #JustPeople